Biotech: Biologics and cell therapy products

3P Biopharmaceuticals has the GMP (Good Manufacturing Practices) certification issued by the AEMPS for the manufacture and release of biological active substances, the release of biological drugs and the release of sterile products for both human and veterinary use and for the manufacture and release of cell therapy product: human allogeneic adult stem cells extracted from hearth tissue an "in vitro“ expanded.

Dámaso Molero, new member of the Board of Directors of Asebio

Dámaso Molero, new member of the Board of Directors of Asebio

Asebio (Spanish Association of Biotechnology Companies) has renewed its presidency and board of directors. Dámaso Molero, General Manager of 3P Biopharmaceuticals, has been elected member of the Board of Directors.

Asebio (Spanish Association of Biotechnology Companies) has renewed its presidency and board of directors. Dámaso Molero, General Manager of 3P Biopharmaceuticals, has been elected member of the Board of Directors.

ASEBIO brings together companies, associations, foundations, universities, research and technology centers that carry out activities directly or indirectly related to biotechnology in Spain.

In order to do this, ASEBIO works closely with regional, national and European governments as well as all the social organizations interested in using biotechnology to improve quality of life, the environment and generating skilled employment.

Dámaso Molero , General Manager of 3P, graduated with a degree in Pharmacy and an Executive MBA degree from the University of Navarra and has experience spanning over 24 years in the chemico-pharmaceutical industry in the areas of Operations and Consulting in multinational companies like Glaxo, Roche, Syntex and Shionogi. His brilliant carrier has taken him to the management of plants thereby involving him in major research projects and engineering at the international level.